Pioneer in mRNA-based therapeutics
Founded in 2000, CureVac is a pioneer in mRNA-based therapeutics and vaccines, developing candidates for COVID-19, rabies, and cancer, with proprietary mRNA stabilization technology.
No hay datos disponibles
No hay elementos FAQ disponibles.